Oscar Health, Inc. (NYSE:OSCR) Receives Average Recommendation of “Hold” from Brokerages

Shares of Oscar Health, Inc. (NYSE:OSCR) have been given a consensus rating of “Hold” by the nine analysts that are currently covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $21.56.

A number of equities analysts have weighed in on the stock. UBS Group assumed coverage on shares of Oscar Health in a research note on Monday, October 7th. They set a “neutral” rating and a $23.00 price target on the stock. Bank of America cut Oscar Health from a “neutral” rating to an “underperform” rating and reduced their target price for the company from $21.00 to $13.50 in a report on Wednesday, November 6th. Finally, Jefferies Financial Group initiated coverage on Oscar Health in a research note on Tuesday, December 10th. They set an “underperform” rating and a $12.00 price target for the company.

Oscar Health Stock Performance

Oscar Health stock opened at $14.12 on Friday. The stock has a fifty day moving average price of $15.10 and a 200 day moving average price of $16.89. Oscar Health has a 52 week low of $9.70 and a 52 week high of $23.79. The firm has a market capitalization of $3.49 billion, a P/E ratio of -235.29 and a beta of 1.70. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.02). Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The company had revenue of $2.42 billion for the quarter, compared to analyst estimates of $2.33 billion. During the same period in the prior year, the company earned ($0.29) EPS. The company’s revenue was up 68.3% compared to the same quarter last year. Equities research analysts anticipate that Oscar Health will post -0.01 earnings per share for the current year.

Insider Activity at Oscar Health

In other news, Vice Chairman Joshua Kushner acquired 276,040 shares of the business’s stock in a transaction on Monday, November 11th. The shares were purchased at an average price of $13.58 per share, for a total transaction of $3,748,623.20. Following the completion of the purchase, the insider now directly owns 5,031,262 shares of the company’s stock, valued at $68,324,537.96. This represents a 5.80 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Thrive Partners Vii Growth Gp, bought 420,819 shares of the firm’s stock in a transaction dated Tuesday, November 12th. The stock was purchased at an average price of $13.68 per share, with a total value of $5,756,803.92. Following the transaction, the director now owns 5,452,081 shares in the company, valued at approximately $74,584,468.08. This represents a 8.36 % increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders have purchased 1,055,478 shares of company stock worth $14,432,852 and have sold 103,610 shares worth $1,847,519. Company insiders own 25.11% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of OSCR. Westfield Capital Management Co. LP acquired a new stake in Oscar Health during the third quarter worth about $27,452,000. JPMorgan Chase & Co. raised its position in shares of Oscar Health by 68.5% during the 3rd quarter. JPMorgan Chase & Co. now owns 2,309,150 shares of the company’s stock worth $48,977,000 after purchasing an additional 938,742 shares during the period. Renaissance Technologies LLC raised its position in shares of Oscar Health by 31.7% during the 2nd quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company’s stock worth $61,478,000 after purchasing an additional 934,600 shares during the period. Point72 Asset Management L.P. bought a new stake in shares of Oscar Health in the 2nd quarter worth approximately $14,716,000. Finally, Soros Fund Management LLC acquired a new position in Oscar Health during the 3rd quarter valued at approximately $12,726,000. 75.70% of the stock is currently owned by institutional investors.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.